D-1080-2017 Class II Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- August 16, 2017
- Initiation Date
- July 26, 2017
- Termination Date
- May 11, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 14,300 vials
Product Description
Hydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10 mg/mL), 50 mL Single Dose Vial. Mfd For: Teva Parenteral Medicines, Inc., Irvine, CA 92618 USA. NDC: 0703-0018-01
Reason for Recall
Presence of Particulate Matter: Silicone oil
Distribution Pattern
Nationwide in the USA
Code Information
Lot #: 560053F, Exp. 01AUG2017